Spero Therapeutics (SPRO) Q2 2024 Earnings Report

603 Followers

SPRO Q2 2024 EPS Results

Actual EPS-$0.33

Consensus EPS-$0.38

Beat/MissBeat by +$0.05

One Year Ago EPS-$0.23

Actual Revenue$6.02M

Expected Revenue$4.90M

Beat/MissBeat by +$1.12M

YoY Revenue Growth+663.58%

QuarterQ2 2024

Date08/05/2024

TimeAfter Close

Conference CallMonday, August 5, 2024

SPRO Upcoming Earnings

Spero Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

SPRO Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 16, 2026	2026 (Q3)	-0.47 / -	-0.13	―
Aug 12, 2026	2026 (Q2)	- / -0.16	-0.03	-433.33% (-0.13)
May 13, 2026	2026 (Q1)	- / -0.13	-0.25	48.00% (+0.12)
Mar 26, 2026	2025 (Q4)	-0.20 / 0.53	-0.38	239.47% (+0.91)
Nov 13, 2025	2025 (Q3)	-0.25 / -0.13	-0.32	59.38% (+0.19)
Aug 12, 2025	2025 (Q2)	-0.38 / -0.03	-0.33	90.91% (+0.30)
May 13, 2025	2025 (Q1)	-0.55 / -0.25	-0.24	-4.17% (-0.01)
Mar 27, 2025	2024 (Q4)	-0.31 / -0.38	0.96	-139.58% (-1.34)
Nov 14, 2024	2024 (Q3)	-0.27 / -0.32	-0.06	-433.33% (-0.26)
Aug 05, 2024	2024 (Q2)	-0.38 / -0.33	-0.23	-43.48% (-0.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed